Figure 4

Event-free survival (A) and overall survival (B) of patients with T-cell acute lymphoblastic leukemia, stratified by genetic lesions in NOTCH1, FBWX7, RAS, and PTEN. Patients with NOTCH1/FBXW7 mutations and RAS/PTEN germline were considered to be a low risk group (n = 32) and the others were classified as a high-risk group (n = 32).